What investment strategy does Vivalto Partners focus on?

Vivalto Partners focuses on Buyout, Growth strategies in the private equity space.

How many portfolio companies does Vivalto Partners have?

Vivalto Partners has 7 active portfolio companies and 1 fund tracked on GP Intel.

Where is Vivalto Partners headquartered?

Vivalto Partners is headquartered in Paris, France.

What is Vivalto Partners's assets under management?

Vivalto Partners manages approximately €700M in assets under management.

When was Vivalto Partners founded?

Vivalto Partners was founded in 2020.

What sectors does Vivalto Partners invest in?

Vivalto Partners invests across Healthcare, Business Services.

Home/GPs/Vivalto Partners

Vivalto Partners

Paris, France·Founded 2020·

Buyout Growth Equity

·vivaltopartners.com

Vivalto Partners is an independent European private equity management company founded in 2021 and based in Paris, specializing in investments in profitable small and mid-sized companies within the healthcare sector across France and…Read full bio

AUM

€700M

Funds

Portfolio

SectorsHealthcareBusiness Services

Key facts

HQParis, France

Founded2020

Websitevivaltopartners.com

Recent exits

No exits recorded yet.

Coverage notes

1 fund tracked, 7 portfolio companies (7 active · 0 realized). Verified weekly from public filings and deal announcements.

About Vivalto Partners

Vivalto Partners is an independent European private equity management company with €700 million of assets under management as of December 2024, founded in 2021 and headquartered in Paris. The firm specialises in investments in profitable small and mid-sized companies within the healthcare sector, with the healthcare-exclusive focus distinguishing Vivalto from generalist mid-cap peers and aligning the platform with the structural growth trends in European healthcare.

Investment thesis

Vivalto targets European small and mid-cap healthcare companies, deploying equity tickets typically ranging from €15 million to €60 million per transaction across both majority and significant minority positions. Sector focus spans the breadth of healthcare verticals including pharma services, medical devices, healthcare services, digital health and selectively biotech businesses. The exclusive healthcare mandate enables deep clinical, regulatory and operational expertise across portfolio companies.

Recent activity

The platform tracks a single dedicated fund vehicle and 7 active portfolio companies across the inaugural deployment of the healthcare-focused PE programme. As a recently established platform (2021 founding), Vivalto is in the active deployment phase with realised exits expected in subsequent years aligned with typical 5-7 year buyout cycles. Detailed buyer names and multiple data available on Pro at €49/month.